Abstract |
The myocardial salvage efficacy of a thromboxane A2/ prostaglandin endoperoxide ( TP) receptor antagonist has not been previously determined in a ferret model of ischemia and reperfusion. Assessments of the reproducibility of infarct size resulting from a 90 min period of occlusion followed by 5 hr of reperfusion of the left anterior descending coronary artery in saline-treated control ferrets revealed a consistent mean level of tissue damage representing 23.1 +/- 1.4% of the left ventricle. In subsequent studies, ferrets were given the thromboxane receptor antagonist SQ 30,741 (1 mg/kg bolus and 1 mg/kg/hr infusion, i.v.) or vehicle. At this dose, SQ 30,741 significantly reduced infarct size from that measured in control ferrets by 44%. Concurrently, the drug produced a 97% inhibition of platelet TP receptors as measured by inhibition of the ex vivo platelet shape change response to U-46,619. Drug administration was not associated with measurable alterations in mean blood pressure, heart rate or the rate-pressure-product. The importance of this finding to clinical utility and the mechanism of the observed cardioprotective action, however, remain unclear. These data indicate that the ferret represents a useful model for the assessment of the myocardial salvage efficacy of TP receptor antagonists and are consistent with attenuation of ischemic myocardial damage by doses of these agents which produce > 96% TP receptor blockade.
|
Authors | A W Gomoll, M L Ogletree |
Journal | Prostaglandins
(Prostaglandins)
Vol. 46
Issue 3
Pg. 233-42
(Sep 1993)
ISSN: 0090-6980 [Print] United States |
PMID | 8234831
(Publication Type: Journal Article)
|
Chemical References |
- Prostaglandin Endoperoxides, Synthetic
- Receptors, Thromboxane
- Vasoconstrictor Agents
- SQ 30741
- Thromboxane A2
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
|
Topics |
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
- Analysis of Variance
- Animals
- Blood Platelets
(drug effects, physiology)
- Blood Pressure
(drug effects)
- Ferrets
- Heart
(drug effects)
- Heart Rate
(drug effects)
- In Vitro Techniques
- Male
- Myocardial Infarction
(blood, pathology)
- Myocardial Ischemia
(blood, pathology)
- Myocardium
(pathology)
- Orchiectomy
- Prostaglandin Endoperoxides, Synthetic
(pharmacology)
- Receptors, Thromboxane
(antagonists & inhibitors)
- Reperfusion
- Thromboxane A2
(analogs & derivatives, antagonists & inhibitors, pharmacology)
- Vasoconstrictor Agents
(pharmacology)
|